Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) shares were down 2.3% during mid-day trading on Tuesday . The company traded as low as $2.10 and last traded at $2.10. Approximately 510 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 9,053 shares. The stock had previously closed at $2.15.
Peak Pharmaceuticals Stock Down 2.3 %
The business has a fifty day simple moving average of $2.40 and a 200-day simple moving average of $3.22.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
See Also
- Five stocks we like better than Peak Pharmaceuticals
- When to Sell a Stock for Profit or Loss
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- What is a Low P/E Ratio and What Does it Tell Investors?
- AMD Gains Momentum With AI: Can It Beat Expectations?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
